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Abstract 
Aim: To find out the chemical equivalence of metformin 500mg of five different manufacturers. Materials and methods: 
Quantitative analysis of five different brand of metformin 500mg was done by spectrophotometry. The reproducibility was 
tested. Throughout the study quantitative analyst was kept blind of the product. Results: The results were analysed to find out 
the chemical equivalence of metformin 500mg. It was found to be chemically equivalent. Conclusion: The above study 
revealed the assay purity of metformin 500mg of five different brands, to that of Indian pharmacopoeia prescribed standards. 
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Introduction 
Chemically equivalent preparations are expected 
to elicit same therapeutic response. The prescribers 
have been encouraged to use non proprietary 
approved names. So that the least expensive brand 
can be supplied and cost is minimised. Metformin , the 
commonly used antidiabetic drug is taken up to find  
out chemical equivalence. The quantitative estimation 
of drugs or their active constituents can be done by 1. 
Bioassay, 2. Physicochemical methods, (like 
chromatographic, flurimetric and mass spectrometric 
techniques), 3. Radio-immunological assay, 4. 
Microbiological methods1.  Metformin Hcl (N,N dimethyl 
imidodicarbonimidic diamide Hcl) is a biguanide 
prescribed for the treatment of type II diabetes and it is 
the drug of choice in obese patients 2,3,4. It increases 
glucose transport across the cell membrane in skeletal 
muscles and it can inhibit the formation of advanced 
glycosylation end product 5,6,7,8,9. 
The proposed method is based on the direct 
determination of metformin with a high degree of 
accuracy and sensitivity. The method is easy, least 
expensive  and is applicable to the quantitative 
determination of metformin Hcl in pharmaceutical 
formulation 10. This was carried out since prescribers 
have been strongly encouraged to use non proprietary 
approved names in N. H. S prescription. So that the 
least expensive brand can be supplied and N.H.S cost 
is minimised 11,12 
The aim of the present study to find out the 
chemical equivalence of metformin 500mg of five 
different brands. 
The objective of the present study is: 
- To find out the assay purity of metformin 
commonly used 
- To suggest the best brand of metformin tablets in 
quantification 
 
Materials and Methods 
Metformin active ingredient (standard) was 
supplied by A to Z pharmaceuticals. It was tested in the 
lab for the purity by measuring its melting point and IR 
spectrophotometry13 prior to testing. No further 
purification was carried out. De-ionized water was used 
for the preparation of different dilution. The commercial 
pharmaceutical formulation sample A, B, C, D, and E. 
They had an expiry of not less than one year at the 
time of study. The brand names were kept confidential. 
The tablets A, B, C, D, and E kept blind to the analyst. 
Assay purity of metformin of different brands was 
carried out using UV spectrophotometer. This was 
done  for reproducibility.  UV spectrophotometric 
method we have as per Indian pharmacopoeia 10mcg 
dilution and specific absorbance as 798 at 232nm14. 
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Since there may be chances of error, we confirmed 
with standard and sample comparison.  
Result 
Assay purity of five different brands of  metformin 
performed.  Assay purity was within the Indian 
Pharmacopoea limits. Reproducibility also obtained. 
Absorbance of metformin at 232 nm with 10mcg water 
dilution is  
Metformin standard -0.8088 
Sample A  -0.7649 
Sample B—0.7760 
Sample C -0.7387 
Sample D -0.7422 
Sample E -0.6657 
Assay purity limit  is 95 – 105% 
For this absorbance, assay purity calculated
 
 
S.No Sample Absorbance Assay Purity % 
1 A 0.7649 95.62 
2 B 0.7760 96.94 
3 C 0.7387 96.23 
4 D 0.7422 96.76 
5 E 0.6657 95.71 
 
Discussion 
This study conducted to identify the potency of a 
brand and to suggest the best brand of metformin 
tablets to the practitioners. Here, after doing the purity 
assay it showed that the five different brands are found 
to be chemically equivalent. Hence the drugs with all 
different brands showed equipotent. Metformin a 
commonly used oral anti diabetic drug can be 
estimated by UV spectrophotometry, HPLC and ion 
pair HPLC method 15,16,17,18,19.  The HPLC method was 
found to be more simple, accurate, economic and 
rapidly acting for metformin identification 19. Another 
study done by Tubino et al 20 reveals that metformin 
can also quantitatively estimated by UV visible diffuse 
reflectance spectrometry very simply. Here in our study 
we did the estimation by UV spectrophotometry. It 
proved that it also can easily and simply estimate 
metformin without any hindrance. The proposed 
method is simple, accurate, precise sensitive and can 
be successfully applied for routine quantitative 
estimation of metformin hydrochloride in bulk and solid 
dosage forms.    
 
Conclusion 
Chemically equivalent preparations are expected 
to elicit same therapeutic response. Here metformin 
500mg in five different brands proved to have equal 
chemical equivalence. So we can interchange or 
replace the drugs if it is required. 
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